Pzena Investment Management LLC Raises Holdings in HCA Healthcare, Inc. $HCA

Pzena Investment Management LLC raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.1% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 101,060 shares of the company’s stock after buying an additional 1,078 shares during the quarter. Pzena Investment Management LLC’s holdings in HCA Healthcare were worth $43,072,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Clearstead Trust LLC lifted its holdings in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Harbor Capital Advisors Inc. boosted its stake in shares of HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after buying an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC purchased a new position in HCA Healthcare in the second quarter valued at $40,000. Compound Global Advisors LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $44,000. Finally, True Wealth Design LLC boosted its holdings in HCA Healthcare by 179.5% in the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after buying an additional 70 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA opened a second freestanding emergency room in a Florida county (St. Augustine), expanding local access and potential outpatient/ER revenue streams as the company pushes more care into lower-acuity, higher-margin settings. Becker’s: HCA opens 2nd freestanding ER in Florida county MSN: HCA Florida Emergency opens for patients in St. Augustine
• Positive Sentiment: An HCA subsidiary acquired a cardiothoracic and vascular physician group, a deal that should boost patient referrals into HCA hospitals, increase capture of surgical volume, and support revenue growth in high-acuity service lines. Becker’s: HCA subsidiary acquires cardiothoracic, vascular physician group
• Positive Sentiment: HCA is investing in EHR unification (alongside peers), an initiative that can lower IT/operational costs, improve care coordination and billing efficiencies — all supportive of margins over time. Becker’s: Why Northwell, HCA and UPMC are betting big on EHR unification
• Positive Sentiment: Analyst/style coverage and positive momentum stories (Zacks, Kalkine) highlight HCA as a value/momentum name, which can attract income/value-oriented and momentum-driven flows. Zacks: Here’s Why HCA Healthcare is a Strong Value Stock Kalkine: HCA Momentum Shines
• Neutral Sentiment: Discussion pieces and analyst roundups examine where HCA shares may head next; these provide context but are unlikely to move the stock materially absent new guidance or earnings surprises. Yahoo Finance: Are Wall Street Analysts Predicting HCA Stock Will Climb or Sink?
• Neutral Sentiment: Local community/CSR activity (National Wear Red Day with Habitat for Humanity) is positive for brand and community relations but has limited direct impact on near-term financials. Post and Courier: HCA marks National Wear Red Day
• Negative Sentiment: An HCA EVP, Michael R. McAlevey, disclosed a sale of 1,694 shares for about $903k, reducing his holdings ~16% — insider selling can signal personal liquidity needs but may create short-term negative sentiment for investors reading into insider actions. SEC filing: SEC filing: Insider sale

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HCA. Sanford C. Bernstein set a $541.00 price objective on shares of HCA Healthcare in a research note on Monday, February 9th. Argus upped their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Leerink Partners lifted their price target on shares of HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Oppenheimer increased their price objective on shares of HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Finally, TD Cowen restated a “buy” rating on shares of HCA Healthcare in a research report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $523.27.

HCA Healthcare Stock Up 0.0%

NYSE:HCA opened at $534.88 on Thursday. The company has a fifty day simple moving average of $486.13 and a two-hundred day simple moving average of $452.76. HCA Healthcare, Inc. has a 52 week low of $295.00 and a 52 week high of $552.90. The company has a market cap of $119.61 billion, a price-to-earnings ratio of 18.85, a price-to-earnings-growth ratio of 1.64 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This represents a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.